Media Coverage

Science

January 15, 2015

In an article for Science, Jocelyn Kaiser writes about how Prof. Robert Weinberg’s company, Verastem Inc., is starting a new round of clinical trials to test the theory that by targeting cancer stem cells, the disease can be controlled. 

Go to News Coverage

Other Coverage